BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25881909)

  • 1. Acute Effects of Muscarinic M1 Receptor Modulation on AβPP Metabolism and Amyloid-β Levels in vivo: A Microdialysis Study.
    Welt T; Kulic L; Hoey SE; McAfoose J; Späni C; Chadha AS; Fisher A; Nitsch RM
    J Alzheimers Dis; 2015; 46(4):971-82. PubMed ID: 25881909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.
    Fisher A; Pittel Z; Haring R; Bar-Ner N; Kliger-Spatz M; Natan N; Egozi I; Sonego H; Marcovitch I; Brandeis R
    J Mol Neurosci; 2003; 20(3):349-56. PubMed ID: 14501019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.
    Marwarha G; Rostad S; Lilek J; Kleinjan M; Schommer J; Ghribi O
    J Alzheimers Dis; 2017; 57(3):907-925. PubMed ID: 28304295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
    Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
    J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
    Liskowsky W; Schliebs R
    Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life.
    Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM
    J Neurosci; 2003 Oct; 23(26):8844-53. PubMed ID: 14523085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine Reduces β-Site AβPP-Cleaving Enzyme 1 Protein Levels Through Induction of Autophagy.
    Wu H; Lu MH; Wang W; Zhang MY; Zhu QQ; Xia YY; Xu RX; Yang Y; Chen LH; Ma QH
    J Alzheimers Dis; 2015; 46(4):863-76. PubMed ID: 25854934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
    Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
    Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε.
    Cisse M; Braun U; Leitges M; Fisher A; Pages G; Checler F; Vincent B
    Mol Cell Neurosci; 2011 Jul; 47(3):223-32. PubMed ID: 21570469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
    Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
    J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.
    Miyamoto M; Kuzuya A; Noda Y; Ueda S; Asada-Utsugi M; Ito S; Fukusumi Y; Kawachi H; Takahashi R; Kinoshita A
    J Alzheimers Dis; 2020; 75(1):173-185. PubMed ID: 32280101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.
    Abd-Elrahman KS; Sarasija S; Colson TL; Ferguson SSG
    Br J Pharmacol; 2022 Apr; 179(8):1769-1783. PubMed ID: 34820835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo.
    Davis AA; Fritz JJ; Wess J; Lah JJ; Levey AI
    J Neurosci; 2010 Mar; 30(12):4190-6. PubMed ID: 20335454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T; Perez-Polo JR; Schliebs R
    J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer's Disease.
    Sathya M; Moorthi P; Premkumar P; Kandasamy M; Jayachandran KS; Anusuyadevi M
    J Alzheimers Dis; 2017; 60(s1):S3-S23. PubMed ID: 28059793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment.
    Jin CH; Shin EJ; Park JB; Jang CG; Li Z; Kim MS; Koo KH; Yoon HJ; Park SJ; Choi WC; Yamada K; Nabeshima T; Kim HC
    J Neurosci Res; 2009 Dec; 87(16):3658-70. PubMed ID: 19533734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice.
    Seo H; Ferree AW; Isacson O
    Eur J Neurosci; 2002 Feb; 15(3):498-506. PubMed ID: 11876777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.